Chemistry:LASSBio-881
From HandWiki
Short description: Chemical compound
 | |
| Identifiers | |
|---|---|
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C23H27N3O6 |
| Molar mass | 441.484 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
LASSBio-881 is a drug which acts as both a non-selective partial agonist of the CB1 and CB2 cannabinoid receptors, and also as an antagonist of the TRPV1 receptor, as well as having antioxidant effects. It has potent anti-inflammatory and anti-hyperalgesic effects in animal studies.[1][2]
- LASSBio-945 has an identical structure sans the nitro FG.
References
- ↑ "Synthesis, pharmacological evaluation and electrochemical studies of novel 6-nitro-3,4-methylenedioxyphenyl-N-acylhydrazone derivatives: Discovery of LASSBio-881, a new ligand of cannabinoid receptors". Bioorganic & Medicinal Chemistry 15 (6): 2421–33. March 2007. doi:10.1016/j.bmc.2007.01.013. PMID 17275312.
- ↑ "LASSBio-881: an N-acylhydrazone transient receptor potential vanilloid subfamily type 1 antagonist orally effective against the hypernociception induced by capsaicin or partial sciatic ligation". British Journal of Pharmacology 159 (8): 1716–23. April 2010. doi:10.1111/j.1476-5381.2010.00672.x. PMID 20401963.
 |  |
